title: [Cryptogenetic ulcerative colitis. Our clinical experience with new therapeutic approaches].
abstract: Sixteen patients with flare-ups of ulcerative colitis were studied. Before and after treatment, patients were submitted to the customary laboratory tests and to x-ray (contrast enema) and endoscopic examination, biopsy material being harvested during the latter. Treatment consisted in the oral administration of 2-4 g 5-ASA daily for 30 days. Only one patient did not tolerate 5-ASA which was withdrawn. All other patients had good or very good results with remission of symptoms.
authors.affiliation: Clinica delle Malattie Tropicali ed infettive, Università degli Studi di Roma La Sapienza.
authors.forename: O
authors.initials: O
authors.lastname: Cigala
authors.forename: M T
authors.initials: MT
authors.lastname: Pancallo
authors.forename: A
authors.initials: A
authors.lastname: Marasco
authors.forename: M
authors.initials: M
authors.lastname: Della Valle
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D003424:Crohn Disease / Q000175:diagnosis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D019804:Mesalamine; D012460:Sulfasalazine / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000636:Aminosalicylic Acids; D012460:Sulfasalazine; D019804:Mesalamine